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CHOP/Ddit3/CEBPZ/GADD153Proteostasis is crucial for life and maintained by cellular chaperones and proteases. One major mitochondrial
protease is the ClpXP complex, which is comprised of a catalytic ClpX subunit and a proteolytic ClpP subunit.
Based on two separate observations, we hypothesized that ClpX may play a leading role in the cellular function
of ClpXP. Therefore, we analyzed the effect of ClpX overexpression on a myoblast proteome by quantitative
proteomics.
ClpX overexpression results in the upregulation of markers of themitochondrial proteostasis pathway, known as
the “mitochondrial unfolded protein response” (UPRmt). Although this pathway is described in detail in
Caenorhabditis elegans, it is not clear whether it is conserved in mammals. Therefore, we compared features of
the classical nematode UPRmt with our mammalian ClpX-triggered UPRmt dataset. We show that they share
the same retrogrademitochondria-to-nucleus signaling pathway that involves the keyUPRmt transcription factor
CHOP (also known as Ddit3, CEBPZ or GADD153).
In conclusion, our data conﬁrm the existence of a mammalian UPRmt that has great similarity to the C. elegans
pathway. Furthermore, our results illustrate that ClpX overexpression is a good and simple model to study the
underlying mechanisms of the UPRmt in mammalian cells.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Maintaining protein homeostasis (proteostasis) has a major impact
on aging and longevity [1]. Imbalanced proteostasis can cause neuro-
degenerative disease, age-related muscle weakness and other patho-
logies [2]. Proteostasis is controlled by molecular chaperones and
stress-induced responses, such as the unfolded protein response path-
ways (UPR). Various organisms show an extended lifespan when cellu-
lar chaperone expression is increased, protein translation is repressed or
protein turnover is increased [3,4]. Molecular chaperones are abundant
in all compartments of the cell and have been well characterized [5–7].
While the endoplasmic and cytosolic UPRs have been extensively stud-
ied, it has recently emerged that the mitochondria are the origin of a
speciﬁc mitochondrial UPR (UPRmt) [8–14].
The mitochondria are double-membrane organelles and the leading
cellular energy producer. Because the mitochondrial matrix is conﬁned
from the cytosol, the mitochondria contain their own chaperones andchemistry and Biophysics, KBC,
roukh).proteases. Two major soluble ATP-dependent AAA+ proteases are in-
volved in the proteolytic degradation of mitochondrial matrix proteins.
The hexameric Lon protease was implicated in quality control and the
maintenance of mtDNA, among others, by controlling the cellular levels
of the Tfam protein [15–19]. Unlike Lon, which recognizes misfolded
protein structures in general [20], the soluble ClpXP protease complex
binds substrates at speciﬁc recognitionmotifs [21,22]. The ClpXP prote-
ase is comprised of ring-shaped hetero-oligomers and is conserved in
prokaryotes, yeast, plants and higher eukaryotes. The ClpX hexameric
subunit contains the ATPase activity, and the double heptameric ClpP
subunit contains the proteolytic activity [21]. Digestion of substrates
by the ClpXP protease complex is a two-step process. First, ClpX,
which has intrinsic chaperone activity [21], recognizes the substrates
based on speciﬁc recognition motifs [22], and binds and partially un-
winds them in an ATP-dependent manner. Second, ClpX delivers the
substrate to the ClpP degradation cavity for proteolysis [21,23]. ClpP
cannot digest proteins without prior ClpX-mediated unfolding. Sub-
strate trapping assays and proteomic approaches in Escherichia coli re-
vealed ﬁve classes of ClpX-speciﬁc recognition motifs [22]. Although
the molecular machine ClpXP has been structurally and functionally
characterized in prokaryotes in some detail, much less is known about
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central player in the UPRmt, and has been linked to aging [9,11]. Accord-
ing to the current Caenorhabditis elegansmodel, peptides resulting from
ClpXP degradation are transported across the inner mitochondrial
membrane by the HAF-1/Mdl1 [11,24] peptide transporter and then
transduce a signal to the nucleus. The key messenger in the cytosol is
the C. elegans ATFS-1 protein [13,25]. The concept that the UPRmt was
relevant for lifespan was initially developed based on studies in
worms with respiratory malfunctions [26,27] and was supported by
ﬁndings in ﬂies [4] and mice [3], but has also been questioned in a
more recent study [28].
We recently reported a mammalian substrate of ClpXP, the mito-
chondrial matrix GTPase NOA1 [29–32]. We showed that increasing
ClpX protein levels alone, without changing the ClpP protein level,
was sufﬁcient to signiﬁcantly increase the degradation capacity of the
ClpXP complex in vivo [29].
This led us to the hypothesis that ClpX, rather than ClpP, controls the
activity of ClpXP in vivo and that ClpX could play an as yet unrecognized
leading role in regulating mammalian ClpXP function and, perhaps,
UPRmt induction.
Here, we present data that support this idea. We show a selective
regulation of ClpX duringmyogenesis and demonstrate that elevated
ClpX protein levels contribute to the initiation of a mammalian
UPRmt-like response. Furthermore, we conﬁrm the involvement of
a retrograde transcriptional regulation pathway mediated by the
UPRmt transcription factor CHOP. In conclusion, we show that the
main features of the C. elegans [9–13,29,33] UPRmt are conserved in




C2C12 mouse myoblasts and HEK293T cells were cultivated under
standard conditions in a humid environment at 37 °C with 8% CO2. Cul-
tivation occurred in Dulbecco's modiﬁed Eagle medium (DMEM) 4.5 g/l
glucose medium supplemented with 10% fetal calf serum (FCS), 2 mM
sodium pyruvate, 2 mM L-glutamine, 100 units/ml penicillin, and
100 μg/ml streptomycin. C2C12 cells were grown to 80% conﬂuence
and split every second day. The cells were seeded the day prior to trans-
fection. Transfection was performed with the TurboFect Reagent
(Fermentas, Germany) according to themanufacturer's protocol, unless
indicated otherwise.
2.2. SILAC labeling
Equal amounts of mousemyoblasts were incubated in Arg- and Lys-
depleted DMEM medium and supplemented with Arg-10 (0.398 mM)
and Lys-8 (0.798 mM), 10% dialyzed FCS and 100 units/ml penicillin
and 100 μg/ml streptomycin (Silantes, Germany). All cells were sub-
cultured for at least ﬁve passages to allow full incorporation of the iso-
topes into the proteome.
2.3. Western blot
At 24–48 hour post-transfection, the protein lysates were prepared
using Laemmli Lysis Buffer (60 mM Tris–HCl pH 6.8, 2% SDS, and
100 mM DTT). The lysates were analyzed using 10% Bis-Tris SDS-PAGE
with 1× MES running buffer, according to the NuPAGE protocol
(Invitrogen). The gels were blotted on nitrocellulose membranes
(Millipore) using the Invitrogen XCell Blotting Device and transfer
buffer containing 20% methanol. The Western blot data were evalu-
ated by densitometry analysis using Quantity One software. The fol-
lowing antibodies were used: anti-ClpX (SAB2107784, Sigma), anti-
beta-Actin (A5441; Sigma), anti-Tom20 (Fl-145) (sc-11415; SantaCruz Biotechnology); anti-Ddit3 (CHOP) (ab11419; Abcam), and
anti-beta-tubulin (ab21057, Abcam).2.4. Cloning of the NOA1, ClpX and CHOP expression plasmids
The NOA1 coding sequence was ampliﬁed from a current plasmid
encoding the NOA1stop sequence by PCR using a proofreading, high-
ﬁdelity Phusion Polymerase (Finnzymes). The enzymatic restriction
sites and a C-terminal Flag tag were introduced by primer design
(5′-BamH1, 3′Flag-tag-stop-SlaI). The Phusion PCR product was A-
tailed using 1 unit of Taq-DNA polymerase (Promega) for 30 min at
70 °C. Subsequently, the A-tailed PCR product was ligated into the
pGemTeasy vector (Promega) using T4 DNA Ligase (Promega) and
was analyzed by sequencing. The insert was isolated by enzymatic
digestion using BamH1 and SlaI and subcloned to the target expres-
sion vector pcDNA5/TO (Invitrogen). The primer sequences includ-
ed: NOA1 f. 5′-TTT AAA GGA TCC ATG CTG CCC GCG CGC CTG GCT
TGC GGG CTG CTC TGC GGG and NOA1 rev 5′-TAA CTC GAG TCA
CTT ATC ATC ATC ATC CTT ATA ATC TCT GTG CTT CTT CAG GTT G.
The CHOP and ClpX coding sequences were ampliﬁed from a C57Bl/
6-derivedmouse cDNA by PCR, similar to the NOA1 ampliﬁcation de-
scribed above. The ClpX coding sequence was cloned with a stop
codon and no tag. The primer sequences included: ClpX fw 5′-GGA
TCC ATG TCC AGT TGC GGC GCT TGT, ClpX rev 5′-CTC GAG TTA GCT
GTT TGC AGC ATC CGC TTG AC, CHOP/Ddit3 f. 5′-AAA GGG AAA
GGA TCC ATG GCA GCT GAG TCC CTG CCT TT, and CHOP/Ddit3 rev
5′-TTT CCC TTT CTC GAG TGC TTG GTG CAG GCT GAC CAT GCG GT.
The ClpX K300Amutant was generated by site-directed mutagenesis
using Agilent AD Pfu Polymerase (Agilent Technologies) with the fol-
lowing oligonucleotides: K300A fw 5′-GGA CCA ACT GGG TCA GGT
GCA ACC CTT CTG GCA CAA AC-3′ and K300A rev 5′-GTT TGT GCC
AGA AGG GTT GCA CCT GAC CCA GTT GGT CC-3′.
To knockdown ClpP in cell culture, we cloned the following shRNA
target sequences into the U6 + 2tetO [34] plasmid: ClpP sh1 5′-GAA
GCA CCT TCC ATT ACT TCT-3′ and ClpP sh2 5′-GCC TCC TTC ACC TTG
ACA AAC-3′. For the knockdown experiments, we mixed both plasmids
(sh1 and sh2) in a 1:1 ratio to increase coverage and, therefore, knock-
down efﬁciency.2.5. FACS (Fluorescence Activated Cell Sorting)
C2C12 cells were seeded 24 h before transfection and co-transfected
with a 1:5 mixture of the pcDNA5/TO-ClpX and pcDNA5/TO-EGFP plas-
mids. At 24 hour post-transfection, the cells were detached with a
trypsin-EDTA solution and transferred to 5% FCS in 1× PBS. The EGFP-
positive cells were enriched by FACS sorting using the BD Aria III Sorter
equipped with the FACS diva 6.0 software version.2.6. In-gel digestion
The protein concentration was determined using a detergent com-
patible Lowry Assay (DC Bio-Rad Assay) according to the manu-
facturer's instructions, and 20 μg of the proteins were loaded onto a
4–12% NuPage Gel (Invitrogen). After the proteins were separated, the
Coomassie (Invitrogen)-stained gel bands were cut into 10 equal slices
per lane and digested with trypsin, as previously described [35]. After
several wash steps, the bands were dehydrated using absolute ethanol
and rehydrated using 50 mM ammonium bicarbonate. The gel bands
were subjected to reduction and alkylation followed by proteolytic di-
gestion with 12.5 ng/μl of a trypsin solution. The resulting peptides
were extracted with three consecutive steps of varying acetonitrile
concentrations and pooled together. Prior to LC–MS/MS analysis, the
peptides were concentrated in a Speed Vac and desalted on C-18 stage
tips made in-house [36].
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The HPLC andMass Spectrometry equipment consisted of a Proxeon
nano EASY LC (now Thermo Fisher Scientiﬁc, USA) coupled to a
QExactive Mass Spectrometer (Thermo Fisher Scientiﬁc, Germany, Bre-
men) via a nano-electrospray ionization source (Thermo Fisher Scientif-
ic, Germany, Bremen). For peptide separation, a binary buffer system
with buffers A (0.1% formic acid) and B (80% ACN, 0.1% formic acid)
was used on a linear 130 min gradient. The initial HPLC conditions
were reconstituted using a gradient of 90% B for washing and 5% B for
re-equilibration, each for 10 min. The mass spectrometer worked in a
data-dependentmode and theMS spectrawere acquired at a resolution
of 70,000 (200 m/z). The ten most intense peaks were isolated within
60 ms at up to 5 × 105 ions and were fragmented in the higher energy
collision induced dissociation (HCD) fragmentation cell followed by
measurement in the high accuracy Orbitrap mass analyzer at a 17,500
(200m/z) resolution. For protein assignment, the ESI-MS/MS HCD frag-
mentation spectrawere correlatedwith theUniprot (www.uniprot.org)
Mus musculus database consisting of 73,952 protein entries using
MaxQuant 1.3.7 [37] combined with the implemented Andromeda
Search Engine [38]. The searches were performed with tryptic speciﬁc-
ity, allowing twomissed cleavages and amass tolerance of 7 ppm forMS
and 6 ppm for MS/MS datasets. Carbamidomethylation at cysteine resi-
dues was set as a ﬁxed modiﬁcation, and oxidation of methionine and
acetylation at the N-terminus of the protein were set as variable modi-
ﬁcations. Theminimal peptide lengthwas deﬁned as 7 amino acids, and
the FDR at protein and peptide level was set to 1%. The searches includ-
ed a protein list of common contaminants that were excluded from the
analysis. Proteins with at least one unique peptide and a ratio count of
two were considered in the analysis. Gene Ontology (GO) annotations
for Cellular Compartment, Molecular Function and Biological Process
were performed in Perseus. Statistical processing and analysiswere per-
formed in the R environment [39]. Fisher enrichment tests for the GO
term analysis were performed using the in-house developed web-
based software ResA3 [40]. p-Values below 0.001 were considered sig-
niﬁcant, using all identiﬁed proteins as the background. The threshold
for up and downregulation of proteins was set to a fold change of 1.5.
2.8. Dual-reporter luciferase assay
We used the dual-reporter Luciferase® Reporter (DLR™) Assay Sys-
tem (Promega), according to the manufacturer's protocol. Brieﬂy,
HEK293T cells were transfected with plasmids encoding a 400 bp frag-
ment of the noa1 promoter upstream of the coding sequence for ﬁreﬂy
(Photinus pyralis) luciferase, the empty plasmid as a negative control or
a plasmid containing the SV40 promoter as positive control. A second
plasmid was co-transfected, which leads to the expression of Renilla
(Renilla reniformis) luciferases, and served as internal control. To reduce
the signal intensities, we used the Fireﬂy and Renilla substrates at a di-
lution of 1:10. Triplicate sequentialmeasurementswere performed 24h
after transfection using an automated plate reader system (MITRAS,
Berthold).
2.9. Chromatin-immunoprecipitation (ChIP)
HEK293T cells were transfected with pcDNA5/TO CHOP using the
calcium phosphate method. Twelve hours after transfection, the medi-
um was changed and the cells were grown for additional 24 h. Then,
fresh medium was supplemented with 100 ng/ml tunicamycin (T7765
Sigma) or the DMSO vehicle. After 24 h, the cell pellet was re-
suspended in 1% formaldehyde/PBS and was incubated for 10 min at
room temperature on a rotating platform to cross-link the DNA-
protein complexes. The reactionwas quenched for 5min by adding gly-
cine (125mMﬁnal concentration). The cells were collected andwashed
twice with ice-cold PBS. Then, the cell pellets were lysed for 10 min on
ice in 500 μL cell lysis buffer (5mMHEPES pH 8.0, 85mMKCl, 0.5% NP-40) supplemented with protease and phosphatase inhibitors (0.5 μg/ml
benzamidine, 2 μg/ml leupeptin, 2mMPMSF, 1mMNa3VO4, and 20mM
NaF). The nuclei were collected by centrifugation (5000 rpm for 5 min)
and lysed in 250 μl of nuclei lysis buffer (50mMTris–HCl pH 8.1, 10mM
EDTA pH 8.0, and 1% SDS) with protease and phosphatase inhibitors as
above. The chromatin was sheared into fragments of 200–500 bp using
Bioruptor® sonication with the high energy setting for 5 cycles, with
30 s “on” and 30 s “off” for a total time of 15min. The sampleswere clar-
iﬁed by centrifugation (14000 rpm, 15min at 4 °C) and diluted to a ﬁnal
concentration of 200 ng/μl in ChIP dilution buffer (0.01% SDS, 1.1% Tri-
ton X-100, 1.2 mM EDTA pH 8.0, 16.7 mM Tris–HCl pH 8.1, 167 mM
NaCl) supplemented with protease and phosphatase inhibitors as
above. The diluted chromatin (150 μg) was used for each immunopre-
cipitation, while 1.5 μg were saved as the “input”. The immunoprecipi-
tation was performed using 3 μg of anti-Ddit3 antibody (ab11419;
Abcam) or non-immune IgG (Mouse IgG, Diagenode kch-819-015) as
negative control. The reaction was performed overnight on a rotating
wheel at 4 °C. After the incubation, 20 μl of pre-blocked protein A
beads (kch-503-008, Diagenode) were added, and the samples were in-
cubated for 2 h at 4 °C on a rotating wheel. The beads were pre-blocked
for 1 h with 0.1% BSA and 0.2 mg/ml sonicated salmon sperm DNA in
ChIP dilution buffer. Then, the beads were pelleted by centrifugation
at 1000 rpm for 30 s and washed consecutively two times for 10 min
in each of the following buffers: low salt buffer (0.1% SDS, 1% Triton X-
100, 2 mM EDTA, 20mMTris–HCl pH 8.1, 150mMNaCl), high salt buff-
er (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH 8.1,
500 mM NaCl), LiCl buffer (10 mM Tris–HCl pH 8.0, 250 mM LiCl, 1%
NP-40, 1% sodium deoxycholic acid, 1 mM EDTA) and TE buffer
(10 mM Tris–HCl pH 8.1, 1 mM EDTA pH 8.0). After the last wash, the
supernatant was completely removed and 270 μl of 10% BT Chelex®
100 resin (Bio-Rad, Germany, cat. 143–2832) was added to the beads
and to the inputs. The samples were incubated for 10 min at 95 °C on
a shaker at 1350 rpm to reverse the cross-linking. Two μl of 10 mg/ml
proteinase K were added and the samples were incubated for 30 min
at 56 °C and 1350 rpm. After this step, the samples were incubated for
10 min at 95 °C and 1350 rpm to denature the proteinase K. Finally,
the samples were centrifuged for 30 s at 1000 rpm, and the supernatant
was collected in fresh tubes and used as a template for quantitative real-
time PCR (QPCR). The QPCR was performed with KAPA SYBR® FAST
(Kapa Biosystems, United Kingdom), according to the manufacturer's
protocol. The following primer pairs were used: ChipP1 fw: 5′-AGG
ACC AAA ACA CGA AGC TAT T-3′, ChipP1 rev: 5′ AGC TAT TTG GGA
GGC CGA G-3′, Chip P2 fw: 5′-ACA TTC CCT TTG AGT TTG ATG C-3′,
and ChipP2 rev: 5′-TTG TAA TTC CAG GGG TGT CAT AA-3′. The relative
occupancy of CHOP/Ddit3 at the two different loci was calculated in
comparison to the total input DNA based on the ct values by the formu-
la: fold enrichment in relation to the input = 2^(ct INP-ct CHIP).
*p b 0.05 was considered signiﬁcant.2.10. RNA isolation and cDNA synthesis
The RNA was isolated with TRIzol reagent (Life Technologies) ac-
cording to the manufacturer's recommendations. DEPC-treated water
was used during the RNA isolation. Brieﬂy, 1 ml of TRIzol reagent was
added to 106 cells. After the addition of 200 μl of chloroform, the sample
was vortexed and centrifuged at 12,000 g for 15 min. The upper, aque-
ous phase was transferred to a new tube with 500 μl of isopropanol
and the RNA was precipitated by centrifugation for 10 min at 12,000 g.
The RNA pellet was washed with 75% ethanol and air-dried. Then, the
RNA pellet was dissolved in DEPC-treated water and stored at−80 °C.
cDNA synthesis was performed with 1 μg of DNase 1-digested RNA
using Superscript II Reverse Transcriptase (Life Technologies), accord-
ing to the manufacturer's recommendations. The resulting cDNA was
diluted 1:10 in 1× TE buffer (10 mM Tris–HCl pH 7.5, 1 mM EDTA
pH 8.0) and stored at−20 °C until use.
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Real-time PCR was performed using the KAPA SYBR FAST Master
Mix (2×) (KAPABiosystems, UnitedKingdom)and aﬁnal concentration
of 200 nMof the forward and reverse Primerswith 2 μl of the 1:10 dilut-
ed cDNA solution. For standardization, we used the housekeeping gene
GAPDH and the ddCt method. Real-time PCR was performed with the
ROCHE LightCycler 480 in biological triplicates (n = 3). The follow-
ing primer pairs were used for the analyses: HSP60/Hspd1 f. 5′-CCC
GCA GAA ATG CTT CGA CT-3′; HSP60/Hspd1 rev 5′-ACT TTG CAA
CAG TGA CCC CA-3′; mtHSP70/HSPA9 f. 5′-TGC CTC CAA TGG TGA
TGC TT-3′; mtHSP70/HSPA9 rev 5′-CAG CAT CCT TAG TGG CCT GT-
3′; HSP90Ab1 f. 5′-CTC GGC TTT CCC GTC AAG AT-3′; HSP90Ab1 rev
5′-GTC CAG GGC ATC TGA AGC AT-3′; Ddit3/CHOP fw 5′-CCT GAG
GAG AGA GTG TTC CAG-3′; Ddit3/CHOP rev 5′-CCT CTT CGT TTC
CTG GGG AT-3′; Ubl5 f. 5′-TGC GCA ACA GAA TCG CAA AT-3′; Ubl5
rev 5′-GTG TCA TCG GTG TTG CAC TT-3′; SatB2 f. 5′-GTC TCC AAA
TCG GAG CAG CA-3′; SatB2 rev 5′-GAA TCA TCA AAC CTC CCA CGG-
3′; ATF5 f. 5′-TTG TTG GTG CAG CCT CCA TT-3′; ATF5 rev 5′-ATC
AGA GAA GCC GTC ACC TGC-3′; GAPDH fw 5′-GAA GCT CAC TGG
CAT GGC CTT-3′; GAPDH rev 5′-CTC TCT TGC TCA GTG TCC TTG CT-
3′; ClpX fw 5′-TGT TGT TGG CCA GTC GTT TG-3′; ClpX rev 5′-AGC
GAT CTG AAG GAA CTC TCT-3′; ClpP fw 5′-TGG GCC CGA TTG ACG
ACA GTG-3′; and ClpP rev 5′-TAG ATG GCC AGG CCC GCA GT-3′.
3. Results
3.1. ClpX is selectively upregulated during myogenesis
Recently, we reported a ClpXP substrate in mammalian cells, which
is the mitochondrial matrix GTPase NOA1 [29,41]. We demonstrated
that simultaneous overexpression of ClpX andNOA1 led to the complete
degradation of NOA1 without modulating ClpP protein levels [29]. This
supported the idea that ClpX was the limiting factor in determining
ClpXP efﬁciency in muscle cells [29]. Because muscle development
(myogenesis) is a largely controlled at the transcriptional level [42],
we wanted to determine whether ClpX and ClpP were selectively regu-
lated at the transcript level. Therefore, we utilized the publically avail-
able Gene Expression Omnibus (GEO) [43,44] database. We compared
two datasets (GDS2412, GDS2265) that were both generated using
C2C12 myoblast cells under different growth conditions.
Comparative analyses revealed that ClpX expression was unaltered
during mitochondrial activation by sodium pyruvate supplementation
(GDS2265), while the ClpP transcript was upregulated (Fig. 1A). Inter-
estingly, the ClpX transcript showed a signiﬁcant ~2-fold increase dur-
ing myotube differentiation (GDS2412), which was not dependent on
ClpP, as the ClpP transcript was not altered (Fig. 1A). This strengthened
our prior assumption that selective modulation of ClpX alone contrib-
utes to the cellular function.
To conﬁrm this at the protein level, we differentiated C2C12 myo-
blasts into myotubes by supplementing the growth medium with 2%
horse serum instead of 10% fetal calf serum. The myoblasts were fully
differentiated intomyotubes after 5 days of differentiation,when robust
ﬁber formation was visible (Fig. 1B). Quantitative real-time PCR mea-
surements conﬁrmed that the myogenesis markers Myf5 and MyoD
were upregulated (Fig. 1C). A Gorilla analysis of the proteins that were
progressively upregulted throughout myogenesis (d0 N d2 N d4) re-
vealed that mitochondrial components are generally upregulated as
an intrinsic part of myogenesis (Supp. Fig. S1). Consistent with the 2-
fold up upregulation of the ClpX transcript (Fig. 1A), we detected a ro-
bust increase of the ClpX protein during myoblast differentiation by
Western blot (Fig. 1D).
Due to the lack of a suitable ClpP antibody, we decided to measure
the total proteome of day 0 myoblasts and day 2 myotubes to analyze
changes in the ClpP protein abundance. We plotted our data in a modi-
ﬁed volcano plot to visualize the proteins that were abundant in allsamples, but at the same time see those that were unique for only one
condition. We included two additional scales for the proteins that
were unique for d0 myoblasts (not detected in myotube d2) or d2
myotubes (not detected in myoblasts) (Fig. 1E). The soluble mitochon-
drial protease LonP1 and the inner membrane anchored AAA-protease
Afg3L2were upregulated duringmyogenesis (Fig. 1E). The data showed
that ClpX was upregulated during myogenesis, thereby conﬁrming the
ClpX Western blot data (Fig. 1D). Furthermore, the data revealed that
the ClpP protein indeed remained unchanged during myogenesis
(Fig. 1E). This shows that the ClpX and ClpP transcript (Fig. 1A) and pro-
tein levels (Fig. 1D, E) were regulated similarly.
In summary,we showed that the subunits of the ClpXPmitochondri-
al protease complex were differentially regulated at both the transcript
and protein levels during mammalian myogenesis. While the proteo-
lytic ClpP subunit remained unchanged, the catalytic ClpX subunit was
signiﬁcantly upregulated at the transcript (2-fold) and protein levels.
3.2. ClpX overexpression induces proteome changes that are restricted to
the mitochondrion
To analyze and isolate the impact of increased ClpX protein levels on
myoblasts, we used SILAC (Stable Isotope labeling of AminoAcids in Cell
Culture) quantitative proteomics (Fig. 2A). We aimed to mimic the ap-
proximately 2-fold transcriptional upregulation of ClpX during myo-
genic differentiation (Fig. 1A). Consequently, we diluted the ClpX
expressing plasmid in a ratio of 1:5 with a plasmid that encoded EGFP.
We performed a crossover experiment by transfecting heavy (argi-
nine-10, lysine-8) and light (arginine-0, lysine-0) labeled C2C12 myo-
blasts with the ClpX/EGFP plasmid mixture. After 24 h, a population of
12–18% of the cells highly expressed EGFP and was enriched by FACS
sorting. Wemixed the heavy ClpX/EGFP lysate with the light control ly-
sate andmixed the light ClpX/EGFP lysate with the heavy control lysate
and assessed the proteome after in-gel digestion by mass spectrometry
(Fig. 2A).
Our quantitative SILAC approach yielded 5584 quantiﬁed proteins
with at least two unique peptides in each condition (Supporting
Table 1). The crossover experiment, in which we performed a label
switch, was highly similar, as represented by a Pearson correlation coef-
ﬁcient of R= 0.73 (Fig. 2B). The relative levels of all quantiﬁed proteins
in the total cell lysates are given in the Supporting Table 1. Approxi-
mately 12.8% (713 out of 5584) of the proteins that we detected were
signiﬁcantly regulated. We analyzed compartment-speciﬁc changes in
our dataset using the Gene Ontology [47,48] cellular compartment an-
notation (Fig. 2B). This analysis revealed that themitochondrial protein
levels were signiﬁcantly increased (black dots), while the cytosolic pro-
tein levels were mostly unaltered or, in some cases, downregulated
(cyan dots) (Fig. 2B). The ribosomal proteins of the 80S cytosolic ribo-
some were not changed and showed a log2 ratio near zero (purple
dots). In contrast, numerous protein subunits of the 55S mitochon-
drial ribosome were signiﬁcantly increased (red dots) (Fig. 2B). Be-
cause the majority of the mitochondrial proteins are encoded in the
nuclear genome, increased mitochondrial import would be required
for increased mitochondrial ribosome biogenesis. In agreement with
this, we see a marked increase of the main mitochondrial membrane
translocase proteins Timm (green dots) and Tomm (orange dots)
(Fig. 2B) and an enrichment of the speciﬁc GO term “transmembrane
transporter activity”.
3.3. ClpX-triggered proteomic changes reﬂect the UPRmt
We concluded from our data analysis that 2-fold ClpX overexpres-
sion was sufﬁcient to signiﬁcantly and speciﬁcally affect the mitochon-
drial proteome ofmyoblasts.Whenwe analyzed the data inmore detail,
we found that the observed proteomic changes paralleled the mito-
chondrial unfolded protein response (UPRmt) pathway, which has not
yet been comprehensively identiﬁed in mammalian cells. To avoid
Fig. 1. The ClpX transcript is selectively upregulated duringmyoblast differentiation. A) Graphic demonstration of the GEO datasets (NCBI) GDS2412 andGDS2265. In GDS2412, Chen et al.
[45] measured the transcriptional changes of C2C12 myoblasts that were differentiated into myotubes in vitro using 2% horse serum. In GDS2265, Wilson et al. [46] C2C12 treated myo-
blastswith increasing concentrations of sodiumpyruvate to investigatemitochondrial activation. ClpXwas selectively upregulated duringmyoblast differentiation andwas not affected by
pyruvate supplementation. B) Lightmicroscopic images of C2C12myoblasts at different stages of differentiation induced by supplementing themediumwith 2%horse serum. Day 0 shows
proliferating myoblasts that were dense at day 1, and started to differentiate and fuse into multinucleated myotubes at day 2. Myotube formation was completed at day 4; the scale bar
corresponds to 50 μm. C) Real-time PCR analysis of the myogenic markers Myf5 and MyoD. D) Western blot analysis of the ClpX protein during myoblast differentiation. E) Extended
volcano plot depicting the myogenesis proteome of d0 myoblasts and d2 myotubes including two scales that show the proteins that were only detected in one condition. The plot
shows the induction of the ClpX protein together with myogenic proteins, such as the myosin light and heavy chains, collagen and troponins. ClpP was abundant in all samples and
was not regulated, and, therefore, the plots are close to zero.
2584 N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591confusion between the classical, nematode UPRmt from the literature
and the response described in this manuscript, we will refer to our
dataset as the “ClpX-triggered UPRmt”. The complete data of the pro-
teome analysis can be found in Supporting Information Table 1, and a
selection of the proteins and protein families that will be discussed in
the following paragraphs are presented in Table 1.The FACS sorted ClpX/EGFP-expressing cells were 10.9-fold enriched
for EGFP and expressed 1.8-fold higher ClpX levels compared to the
control cells. This precisely reﬂected the 1:5 ClpX:EGFP ratio with
which we mixed the expression plasmids. Interestingly, the ClpP and
LonP1 protein levels were unchanged, and the intermembrane space
protease Omi/Htra2 was also unaffected (Table 1).
Fig. 2. SILAC-based quantitative proteomicmeasurementswith C2C12 cells that express ClpX and the selectionmarker EGFP. A) Schematicworkﬂow: C2C12myoblasts were labeledwith
heavy (Arg10, Lys8) or light (Arg0, Lys0) amino acids. Heavy and light cells were transfectedwith ClpX/EGFP plasmids in a ratio of 1:5. Twenty-four hours later, the cells were trypsinized
and FACS sorted for EGFP (~15% of total cells). The heavy ClpX/EGFP lysatewasmixed 1:1with the light control lysate and, in the reverse experiment, the light ClpX/EGFP lysatewasmixed
1:1with theheavy control lysate. In-gel digestionwasperformed after SDS-PAGE, followedbynano LC–MS/MSwith data evaluation byMaxQuant. B)A replicate plot ofmass spectrometry
based analysis. A total of 5584 proteins were identiﬁed. Themitochondrial proteome is marked with gray dots and the cytosolic proteome with cyan dots. Members or themitochondrial
55S ribosomewere upregulated (red dots), while members of the cytosolic 80S ribosome remained unchanged with log2 ratios near zero (purple dots). Mitochondrial import proteins of
the TIM and TOM complex were up regulated (green and orange dots).
2585N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591The GO analysis (Fig. 2B) highlighted a clear transcriptional ac-
tivation of mitochondrial genes. Therefore, we analyzed the ex-
pression of the transcription factor NRF1, which regulates the
transcription of numerous housekeeping mitochondrial proteins.
In our dataset, NRF1 was upregulated 1.8-fold, reﬂecting thetranscriptional activation of a mitochondrial biogenesis program.
The UPRmt is a proteostasis response that involves the CHOP-
mediated transcriptional activation of nuclear biogenesis genes
[12]. The CHOP protein was 1.9-fold more abundant after ClpX ex-
pression (Table 1).
Table 1
A list of selected proteins from the ClpX/EGFP SILAC experiment demonstrates UPRmt
pathway induction. An illustrative family member was chosen to represent protein
families or protein groups that are discussed in the text. Proteins were considered
upregulated when the heavy ClpX/EGFP vs. light control fold change was N1.5 (green,
arrow up), and proteins were considered downregulated when the fold change was
b0.65 (red, arrow down). Proteins with a H/L ratio N0.65 and b1.5 were considered
unchanged (yellow, arrow horizontal).
2586 N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591Mitochondrial function depends on a functional oxidative phosphory-
lation (OXPHOS) system and the adaptation of the supportingmitochon-
drial metabolic pathways to provide co-factors. The nuclear encoded
subunits of the OXPHOS complexes III (CoenzymeQ-cytochrome c oxido-
reductase) and IV (Cytochrome C oxidase; COX) were increased, while
the levels of the OXPHOS complex I and II proteins were unaltered. Addi-
tionally, the protein components of the mitochondrial ATPase were not
changed (Table 1). The pyruvate dehydrogenase complex producesAcetyl-CoA and is an essential intermediate for the TCA-cycle and
OXPHOS system function. The three subunits of the mitochondrial pyru-
vate dehydrogenase (PDH) complex that convert pyruvate into Acetyl-
CoA were upregulated ~1.5-fold. The isocitrate dehydrogenase (IDH)
complex exists in three isoforms. IDH1 and IDH2 are cytoplasmic and
were downregulated or unchanged, whereas the level of the IDH3 mito-
chondrial isoform was signiﬁcantly increased by 1.7-fold (Table 1). The
IDH3 reaction is one of the irreversible steps of the TCA cycle and is sub-
strate-controlled. Increased IDH3 protein amounts would prevent sub-
strate inhibition and increase NADH production for OXPHOS.
The mitochondrial DNA (mtDNA) encodes 13 essential OXPHOS
subunits, the necessary tRNA genes and two ribosomal RNAs for themi-
tochondrial ribosome. Hence, the mitochondria possess their own tran-
scription and translation machinery. Nearly all components of the 55S
mitochondrial ribosomewere upregulated,while the cytosolic ribosom-
al proteins were unchanged (Table 1, Supporting Table 1). Additionally,
themitochondrial elongation factor EFG, EFTS and EFTU proteinswere in-
creased by ~1.6-fold, thereby ensuring functional translation when the
number of mitochondrial ribosomes rises. Other crucial regulators of
mitochondrial protein synthesis were also upregulated, e.g., mTerf3
(also called mTerfD1) [49] — 1.5-fold, NOA1 [29–32] — 1.7-fold and
the mitochondrial mRNA stabilizing protein LRPPRC — 1.7-fold. We
also observed a clear signature for the upregulation of mitochondrial
transcription. All of the key proteins were increased (TEFM, TFAM,
TFB2M and POLRMT) (Table 1). In contrast, the mtDNA maintenance
proteins (e.g., SSBP1) were unaltered (Supporting Table 1). This indi-
cates that the ClpX-triggered UPRmt activates a broad and, at the same
time, highly mitochondria-selective nuclear biogenesis program.
We compared the regulation of cellular chaperones to determine
whether the ClpX-triggered proteome changes were speciﬁc. The pro-
tein expression of cytosolic chaperones (HSP90, Bag2, Bag3, and
HSP40) and ER chaperones (GGRP94, GRP78, ERp29, ERp44, calreticulin,
and protein disulﬁde isomerase) were unaltered (Table 1). However,
the expression of the mitochondrial chaperones (HSP10, mtHSP60,
mtHSP70) was signiﬁcantly increased, including the HSP60 protein,
which is considered a hallmark of the UPRmt (Table 1). This clear sepa-
ration of chaperone regulation further deﬁned the margins of the
ClpX-triggered UPRmt and conﬁrmed the suitability of the system as a
model to study mitochondrial matrix-speciﬁc UPRmt in mammalian
cells.
Beyond these classical proteome changes, we have also observed en-
richment in the Gorilla term “transmembrane transporter activity”. Pro-
teins that are involved in mitochondrial protein import were generally
upregulated (Fig. 2B). In general, members of the Translocase of the
Outer Membrane (TOM) and the Translocase of the Inner Membrane
(TIM) families were increased (Table 1). In addition to the Timm and
Tomm subunits, Sam50, a member of the SAM complex that enables
the insertion of proteins into the outer mitochondrial membrane, also
showed higher abundance. Moreover, Mia40, a member of the MIA
complex that facilitates intermembrane space folding of imported pro-
teins, was upregulated. Numerous mitochondrial matrix proteins carry
an N-terminal targeting presequence, which is processed by the mito-
chondrial matrix presequence protease Pitrm1. Pitrm1 was also 1.7-
fold upregulated. In agreement with the elevation of the OXPHOS pro-
teins, the core component of the inner membrane insertion machinery,
theOxa1l protein, showed a 1.7-fold increase. In summary, all of the im-
port machineries into the mitochondrial compartment were upregulat-
ed in the ClpX-triggered UPRmt.
3.4. CHOP mediates ClpX-initiated retrograde transcriptional activation
The general unbiased GO analysis and the detailed analysis of select-
ed protein families and pathways led us to the conclusion that ClpX in-
duced the UPRmt in myoblasts.
We sought to analyze one crucial underlying transcriptional sig-
naling cascade to provide more evidence for the sustainability of this
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characterized by retrograde transcriptional activation of mitochondrial
genes, such as HSP60. This transcriptional activation is primarily medi-
ated by the transcription factor CHOP (also known as Ddit3, CEBPZ or
GADD153) [8,12], which is upregulated in our dataset. Furthermore,
the nematode UPRmt signaling is triggered by ClpXP-derived pep-
tides. In other words, the ClpXP substrates should mediate the
CHOP-dependent transcriptional activation [10,11,24]. Because the
CHOP protein was upregulated 2-fold in our dataset (Table 1), we
wanted to address to what degree this pathway was conserved in
mammals in more detail.
In a previous study,we showed that NOA1 is amammalian substrate
of ClpXP [29]. Controversially, we noticed a 1.7-fold upregulation after
ClpX expression (Table 1). Because NOA1 is an important regulator of
mitochondrial function [29–32,41], we concluded that NOA1 may be
transcriptionally upregulated by theUPRmt to compensate for the paral-
lel increase in degradation by the more active ClpXP. Therefore, we
screened the noa1 gene promoter for putative CHOP binding sites [8],
andwe indeed found a putative CHOP consensus sequence (P1) located
approximately 400 bp upstream of the initiation codon (Fig. 3A). To
show that CHOP mediated the ClpX-triggered NOA1 upregulation in
our proteomic dataset, we performed a dual-luciferase promoter assay
in HEK293T cells. The expression of the luciferase gene was either driv-
en by the SV40 promoter or by a 400 bp fragment of the endogenous
noa1 promoter (Fig. 3B). Promoter-less luciferase served as a negative
control (Fig. 3B). As an internal control, we normalized the luciferase
signal to Renilla luminescence. As expected, there was no detectable lu-
ciferase activity with the empty promoter and only a basal activation
with the SV40 promoter (Fig. 3C). In agreement with our proteomic re-
sults, ClpX overexpression led to a 5-fold activation of the noa1 promot-
er. CHOP alone failed to induce noa1 promoter activity under basal
conditions (Fig. 3C). However, transcriptional co-factors of CHOP
may be missing under these basal conditions [12]. Tunicamycin
treatment, which induces endoplasmic reticulum (ER)-stress, can
be used to induce the expression of these transcriptional co-factors
[12]. CHOP signiﬁcantly activated the noa1 promoter by 10-fold
after tunicamycin addition. This conﬁrmed that CHOP was sufﬁcient
for the activation of the noa1 promoter, but requires co-factors that
can be provided either by ClpX expression or by tunicamycin treat-
ment. In the nematode UPRmt pathway, the ClpXP-derived peptides
and a mitochondrial inner membrane peptide exporter are involved
in themitochondria-to-nucleus signaling [11,13]. Therefore, we test-
ed whether NOA1 itself could trigger the activation of its own pro-
moter. However, NOA1 expression had no effect on its promoter
activity compared to control cells (Mock) (Fig. 3C). To irrevocably
conﬁrm that the predicted putative CHOP binding sites in the noa1
promoter were responsible for the CHOP-dependent activation, we
performed chromatin-immunoprecipitations (ChIP). For the ChIP
experiments, we used primers that ampliﬁed either the noa1 pro-
moter, including the putative CHOP binding site (P1) [14], or a region
in Exon 3 (P2) that served as the negative control (Fig. 3A). In accord
with the luciferase results, CHOP alone did not bind the noa1 pro-
moter (Fig. 3D). However, in the presence of transcriptional co-
factors (tunicamycin), we measured a massive enrichment of CHOP
at the noa1 promoter (P1) (Fig. 3D). CHOP was not enriched at the
control region (P2) (Fig. 3E). The CHOP enrichment at the noa1 pro-
moter after tunicamycin treatment was not due to increased cellular
CHOP protein levels (Fig. 3F). In summary, the noa1 promoter was
transcriptionally activated by the transcription factor CHOP, which
is dependent on other co-factors that can be provided by parallel
tunicamycin treatment.
We used a ClpP knockdown approach to conﬁrm that response
depicted in our ClpX-triggered proteome was mediated by the pro-
teolytic activity of the ClpXP protease complex and not due to the
ClpP-independent chaperone activities of ClpX. As a control experiment,
we used a catalytically dead version of ClpX, ClpXK300A [50] (Supp.Fig. S2A). We transfected C2C12 cells with wild type ClpX, ClpXK300A
and an shRNA plasmid that targeted ClpP. Quantitative Real-Time PCR
(QPCR) conﬁrmed an increase of ClpX levels and the repression of
ClpP (Supp. Fig. S2B). QPCR showed that ClpX selectively stimulatedmi-
tochondrial chaperone (HSP60 and HSP70) expression, while the cyto-
solic chaperone HSP90 was unaffected (Fig. 3G). These results were
consistent with our ﬁndings on the protein levels. ClpX transfection
combinedwith ClpP knockdown abolished the ClpX-mediated response
completely. This shows that the response described here is dependent
on a proteolytically functional ClpXP complex. Moreover, the catalyti-
cally dead ClpXK300A mutant did not affect chaperone expression
(Fig. 3G). Additionally, we used QPCR to examine the transcriptional
network underlying the ClpX-triggered UPRmt by investigating selected
transcription factors. In accord with the proteome dataset (Table 1), the
CHOP transcript was increased 2-fold after ClpX overexpression
(Fig. 3H). The transcription factors Ubl5 and SatB2 act in concert with
CHOP in UPRmt signaling [33]. Because our proteome was devoid of
the Ubl5 and SatB2 peptides, we analyzed their RNA levels in response
to ClpX overexpression by QPCR. Both Ubl5 and SatB2 showed a 3-fold
upregulation that was dependent on ClpX expression. ClpXK300A did
not activate Ubl5 and SatB2, and ClpP knockdown abolished the re-
sponse (Fig. 3H). Interestingly, the transcription factor ATF5, which
plays a role in other cellular protein quality control pathways, is highly
upregulated by ClpX (Fig. 3H). In conclusion, we have shown that there
are highly similar signatures between the nematode UPRmt and our
mammalian ClpX-triggered UPRmt response.
4. Discussion
Myogenesis is accompanied by mitochondrial biogenesis, which is
generally indispensable for developmental processes. The transcription-
al basis of myogenesis has been greatly studied and the factors involved
are well known [42,51]. The regulatory circuits underlying classical mi-
tochondrial biogenesis involving the NRF and PGC1 proteins have also
been extensively studied [52,53]. The downside of biogenesis is the po-
tential for increased proteotoxic stress and the need for protein quality
control pathways. The mitochondria have the capacity to propagate
such intrinsic stress signals to the nucleus via a retrograde response
pathway. Primarily, this involves the loss of the mitochondrial mem-
brane potential and is directly linked to the mitophagy and autophagy
pathways [54,55].
ClpXP is one of the major protease complexes in the mitochondrial
matrix and is comprised of a ClpX subunit and a ClpP subunit. Our
studywas based on the observation that ClpXwas selectively upregulat-
ed during myogenesis, while ClpP remained unchanged. Together with
our earlier ﬁnding showing that ClpX was sufﬁcient to increase the
catabolic capacity of the entire ClpXP complex in muscle cells [29], we
hypothesized that ClpX may play an as yet uncharacterized important
role in the mitochondria and during myogenesis.
In this study, we demonstrated that ClpX overexpression induced
proteome changes paralleling the mitochondrial unfolded protein re-
sponse (UPRmt). This is, to our knowledge, the ﬁrst proteome-wide por-
trayal of the mammalian UPRmt. Due to the lack of information on the
mammalian UPRmt, we have investigated the hallmarks of the nema-
tode UPRmt in our system.
We showed that the ClpX-triggeredUPRmt covered themitochondri-
al matrix proteome and numerous proteins linked to the import of mi-
tochondrial proteins and mitochondrial function (Table 1). The UPRmt
has been deﬁned by the transcriptional activation of mitochondrial
chaperones [14,56]. The expression level of HSP60 is considered a hall-
mark to deﬁne UPRmt activity [3,9]. Accordingly, the HSP60 chaperone
was upregulated in the ClpX-triggered UPRmt. The UPRmt target genes
contain responsive elements in their promoter regions that corres-
ponded to CHOP transcription factor binding sites [8,33]. Notably, the
CHOP protein also participates in other stress response pathways, such
as the ER-derived unfolded protein response (UPRER) pathway [8,12].
Fig. 3. The transcription factor CHOP binds to the noa1 promoter. A) Schematic representation of the putative CHOP binding site (P1) in the noa1 promoter. The primer binding sites were
selected to amplify site P1 and the control region in Exon 3, named P2. B) Schematic outline of the luciferase assay. We used the SV40 promoter upstream of the Fireﬂy luciferase coding
sequence as a positive control. A promoter-less plasmidwas used as a negative control. To assess the noa1 promoter activity, 400 base pairs upstream of the noa1 transcriptional start site
were cloned upstream of the luciferase gene. C) The luciferase assay in HEK293T cells showed basal activity of the SV40-luciferase plasmid and almost no activity of the promoter-less
luciferase. The noa1 promoter was activated by ClpX overexpression. While inactive under basal conditions, CHOP stimulated noa1 promoter activity when the cells were treated with
tunicamycin in parallel. D) Chromatin immunoprecipitation (ChIP) revealed that CHOP binds to the putative CHOP consensus site, P1, when tunicamycin was applied in parallel (axis
scale: 0–1500). E) The P2 control region in Exon 3 of the noa1 promoter was unaffected by CHOP and/or tunicamycin (axis scale: 0–150). F) Western blot analysis of CHOP protein
expression levels used in the ChIP experiment show that tunicamycin treatment did not affect the CHOP protein levels. G) QPCR analysis of the mitochondrial chaperones HSP60/
Hspd1, mtHSP70/HSPA9 and the cytosolic chaperoneHSP90Ab1. C2C12 cells (5 × 106 cells)were transfectedwith 3 μg of the expression plasmid and 1 μg of the ClpP knockdown plasmid,
as indicated. H) QPCR analysis of the UPRmt related transcription factors CHOP/Ddit3, Ubl5, SatB2 and ATF5.
2588 N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591Because CHOPwas upregulated in our dataset, we testedwhether CHOP
was directly involved in ClpX-triggered mammalian UPRmt transcrip-
tional activation [8,12]. We conﬁrmed that CHOP, in concert with
other co-factors, physically interactedwith and activated theNOA1 pro-
moter, which we utilized as a representative for other mitochondrial
metabolic genes (Fig. 3A–F). These data highlighted that the similarities
between the nematode UPRmt and our ClpX-triggered UPRmt areconsistent beyond the proteome level. We also show that the ClpX-
triggered UPRmt also increased the level of CHOP co-factors because
both the Ubl5 and SatB2 [33] transcription factors were clearly in-
creased (Fig. 3H). This observation parallels the nematode UPRmt. In
nematodes, the ATFS-1 protein acts upstream of Ubl5 and Dve-1 (the
C. elegans homologue of SatB2) [13]. One candidate for such an ATFS-
1-like role in the mammalian system would be ATF-5, a key regulator
Fig. 4. Themammalian ClpX-triggeredUPRmt pathway is amitochondria-derived biogenesis program for differential metabolic needs during development.Myogenesis is accompanied by
increasedmitochondrial biogenesis, where the catalytic ClpX subunit of the mitochondrial ClpXP protease is upregulated 2-fold, while expression of the proteolytic ClpP subunit remains
unchanged. As a result, the cellular proteome undergoes changes thatmirror the C. elegansmitochondrial unfolded protein response (UPRmt). Consistentwith the UPRmt, the transcription
factors CHOP, Ubl5 and SatB2 are upregulated andmediated ClpXP-dependent transcriptional activation ofmitochondrial biogenesis factors (e.g., NOA1) and chaperones (e.g., mtHSP60).
The precise underlying cellular signaling cascade and the factors involved remain elusive. Alternative stress signalingmolecules such as ATF5 are attractive candidates for future studies as
the primary regulators of the mammalian UPRmt. In summary, we show in this study that the mammalian UPRmt seems to be relatively well-conserved from the nematode system. We
conclude that manipulating the mitochondrial ClpX protein levels is an authentic model to study the UPRmt in mammalian cells. Furthermore, we postulate that the UPRmt is an intrinsic
part of myogenesis and, presumably, other mammalian developmental processes.
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(Fig. 3H), while neither the ER chaperones nor the apoptosis markers
were activated (Table 1).
A central aspect of the nematode UPRmt is the necessity of a func-
tional ClpP subunit because the UPRmt signaling is transduced by
ClpXP-derived peptides derived [13]. Our QPCR approach conﬁrmed
that the stimulation of the mitochondrial chaperones and the UPRmt-
related transcription factors is highly dependent on the proteolytic ac-
tivity of a functional ClpXP protease complex. Both catalytically dead
ClpXK300A and ClpP knockdownabolished the ClpX-triggered response
(Fig. 3G, H).
In nematodes, the ClpXP substrates are digested, and it is the ac-
tual peptides that trigger the UPRmt [9–11]. We show here that the
mammalian ClpX-triggered UPRmt shares features with the nema-
tode UPRmt. However, the expression of the sole ClpXP substrate
tested (NOA1) [29] did not trigger its own promoter activation and,
thus, a UPRmt response (Fig. 3C). Although there are clear similarities
between the C. elegans UPRmt and the mammalian system, more in-
vestigation is needed to clarify the precise underlying mammalian
signaling pathways.
Additionally, our ClpX-triggered UPRmt dataset already highlights
some novel aspects that have not been deciphered by other approaches.
Beyond classical HSP60 activation and the upregulation of the transcrip-
tion factors CHOP, Ubl5, SatB2 and ATF5, our data show new aspects of
the UPRmt, including the activation of oxidative phosphorylation
(OXPHOS). While the largest of the OXPHOS complexes, complex I,
remained unchanged, we detected a signiﬁcant elevation of complexes
III and IV. OXPHOS complex I has been shown to be the scaffold for
super-complex formation [57] (Table 1). A super-complex deﬁnes an
assembly of several sub-complexes in variable stoichiometry. Due to
the close proximity of the OXPHOS complexes in this type of super-
complex, the electron shuttling capacity is enhanced and respiratory ef-
ﬁciency is, therefore, increased. Our data suggest that during ClpX-
triggered UPRmt, OXPHOS function could be optimized solely by chang-
ing the stoichiometry of OXPHOS complexes III and IV. This could then
rapidly lead to altered super-complex assembly and enhanced respira-
tory activity [57,58]. Supporting this idea, the pyruvate dehydrogenase
complexwas increased by the ClpX-triggered UPRmt (Table 1). Pyruvate
dehydrogenase contributes to the transformation of pyruvate into
Acetyl-CoA, which is needed for the TCA cycle to produce NADH.
These increased NADH levels would, in turn, be needed to support in-
creased OXPHOS activity. This indicates that the UPRmt globally adaptsthe mitochondrial metabolism to cellular needs. We are convinced
that the ClpX-triggered UPRmt is a simple and suitable model to study
the mammalian UPRmt in more detail. Most importantly, the ClpX-
triggered UPRmt is, in our opinion, the ﬁrst pure and unbiased model
system (Fig. 4).
Several approaches have been used to analyze the UPRmt in various
species, and some studies support the hypothesis that the nematode
UPRmt may be partially conserved in higher eukaryotes, such as
Drosophila melanogaster [4]. However, comprehensive and conclusive
data on UPRmt signaling in mammals were lacking. In mammalian
cells, the UPRmt has been addressedmainly by altering protein function
or by the generation of high amounts of misfolded proteins [3,14,56].
Numerous approaches altered ClpP protein levels or activity [9,59,60].
However, the ClpP [60] knockoutmouse is viable andwas characterized
as a model for human Perrault syndrome, a disease connected to ClpP
mutations. The ClpP knockout mouse did not show a consistent UPRmt
phenotype. Other methodologies to study the UPRmt were either
mitochondriotoxic (ethidium bromide, doxycycline) [14,56,61] or in
the context of metabolic disease [62]. These analyses likely blend sever-
al activated cellular signaling pathways, and it has been rather difﬁcult
to distinguish between the UPRmt regulators and effectors. Lack of a
model system for uncorrupted UPRmt may also be the reason why rela-
tively few aspects of the nematode URPmt have been conﬁrmed for the
mammalian system. The ClpX-triggered UPRmt model may ﬁll this gap.
Understanding the UPRmt would contribute to the understanding of
the aging process, including the controversial longevity phenotypes [3,
28,59].
Finally, it is important to decipher to what extent the UPRmt is ben-
eﬁcial for the cell. It has been suggested that the duration of the UPRmt
may determine whether the UPRmt is advantageous or results in au-
tophagy and, subsequently, apoptosis [10,33]. Notably, our proteomic
dataset of the ClpX-triggered UPRmt is devoid of any signs of apoptosis.
Moreover, it seems that the pro-apoptotic signals are even repressed,
for example by the downregulation of the AKT and S100 family of pro-
teins (Table 1). Hence, we postulate that the ClpX-triggered UPRmt is a
beneﬁcial response, which speciﬁcally contributes to the maintenance
ofmitochondrial proteostasis and the ﬁne-tuning ofmitochondrialmet-
abolic activity. Based on our observations of differential ClpX regulation
during myogenesis, we postulate that the UPRmt is an intrinsic part of
myogenesis (Fig. 4) and perhaps other developmental processes. This
is in accord with the current concept that the UPRmt is responsible for
the “synchronization of genomes” [63], which is especially vital under
2590 N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591growth conditions. In any case, it will be essential to deﬁne the term
“UPRmt” very accurately to reach a consensus about its precise connota-
tions in metabolism.
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doi.org/10.1016/j.bbamcr.2015.06.016.
Author contributions
T.B. supervised the study. N.A. designed the study, performed the ex-
periments, analyzed and interpreted the data and wrote the manu-
script. A.I. planned, performed and analyzed the ChIP experiments.
N.A. and S.W. drafted the manuscript. S.H. processed the MS–MS sam-
ples. H.N. performed bioinformatics analyses on the mass spectrometry
data, and M.K. supervised the mass spectrometry measurements.
Funding
This work was supported by the Max-Planck-Society (stipend N.A.),
the Deutsche Forschungsgemeinschaft (Excellence Cluster Cardio-
Pulmonary System (Br1416) and Sonderforschungsbereich TR81-TP
A02), the LOEWE (Landes-Offensive zur Entwicklung Wissenschaftlich-
ökonomischer Exzellenz), the Center for Cell and Gene Therapy, and
the German Center for Cardiovascular Research.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
Acknowledgments
This work was supported by the Max-Planck-Society (stipend N.A.),
the DFG (Excellence Cluster Cardio-Pulmonary System [ECCPS], Br1416,
and SFB TR81-TP A02), the LOEWE (Landes-Offensive zur Entwicklung
Wissenschaftlich-ökonomischer Exzellenz) Center for Cell and Gene
Therapy, and the German Center for Cardiovascular Research.
References
[1] R.I. Morimoto, Proteotoxic stress and inducible chaperone networks in neuro-
degenerative disease and aging, Genes Dev. 22 (2008) 1427–1438.
[2] M.S. Hipp, S.H. Park, F.U. Hartl, Proteostasis impairment in protein-misfolding and
-aggregation diseases, Trends Cell Biol. 24 (2014) 506–514.
[3] R.H. Houtkooper, L. Mouchiroud, D. Ryu, N. Moullan, E. Katsyuba, et al., Mitonuclear
protein imbalance as a conserved longevity mechanism, Nature 497 (2013)
451–457.
[4] E. Owusu-Ansah, W. Song, N. Perrimon, Muscle mitohormesis promotes longevity
via systemic repression of insulin signaling, Cell 155 (2013) 699–712.
[5] B. Bukau, J. Weissman, A. Horwich, Molecular chaperones and protein quality
control, Cell 125 (2006) 443–451.
[6] D. Ron, P. Walter, Signal integration in the endoplasmic reticulum unfolded protein
response, Nat. Rev. Mol. Cell Biol. 8 (2007) 519–529.
[7] W. Voos, Chaperone-protease networks in mitochondrial protein homeostasis,
Biochim. Biophys. Acta 1833 (2013) 388–399.
[8] J.E. Aldridge, T. Horibe, N.J. Hoogenraad, Discovery of genes activated by the mito-
chondrial unfolded protein response (mtUPR) and cognate promoter elements,
PLoS One 2 (2007) e874.
[9] C.M. Haynes, K. Petrova, C. Benedetti, Y. Yang, D. Ron, ClpP mediates activation of a
mitochondrial unfolded protein response in C. elegans, Dev. Cell 13 (2007) 467–480.
[10] C.M. Haynes, D. Ron, The mitochondrial UPR— protecting organelle protein homeo-
stasis, J. Cell Sci. 123 (2010) 3849–3855.
[11] C.M. Haynes, Y. Yang, S.P. Blais, T.A. Neubert, D. Ron, The matrix peptide exporter
HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7
in C. elegans, Mol. Cell 37 (2010) 529–540.
[12] T. Horibe, N.J. Hoogenraad, The chop gene contains an element for the positive reg-
ulation of the mitochondrial unfolded protein response, PLoS One 2 (2007) e835.
[13] A.M. Nargund, M.W. Pellegrino, C.J. Fiorese, B.M. Baker, C.M. Haynes, Mitochondrial
import efﬁciency of ATFS-1 regulates mitochondrial UPR activation, Science 337
(2012) 587–590.
[14] Q. Zhao, J. Wang, I.V. Levichkin, S. Stasinopoulos, M.T. Ryan, et al., A mitochondrial
speciﬁc stress response in mammalian cells, EMBO J. 21 (2002) 4411–4419.
[15] B. Lu, J. Lee, X. Nie, M. Li, Y.I. Morozov, et al., Phosphorylation of human TFAM inmi-
tochondria impairs DNA binding and promotes degradation by the AAA+ Lon pro-
tease, Mol. Cell 49 (2013) 121–132.[16] E. Gur, The Lon AAA+ protease, Subcell. Biochem. 66 (2013) 35–51.
[17] E. Gur, M. Vishkautzan, R.T. Sauer, Protein unfolding and degradation by the AAA+
Lon protease, Protein Sci. 21 (2012) 268–278.
[18] Y. Matsushima, Y. Goto, L.S. Kaguni, Mitochondrial Lon protease regulatesmitochondri-
al DNA copy number and transcription by selective degradation of mitochondrial tran-
scription factor A (TFAM), Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 18410–18415.
[19] B. Lu, S. Yadav, P.G. Shah, T. Liu, B. Tian, et al., Roles for the human ATP-dependent Lon
protease in mitochondrial DNA maintenance, J. Biol. Chem. 282 (2007) 17363–17374.
[20] E. Gur, R.T. Sauer, Recognition of misfolded proteins by Lon, a AAA(+) protease,
Genes Dev. 22 (2008) 2267–2277.
[21] T.A. Baker, R.T. Sauer, ClpXP, an ATP-powered unfolding and protein-degradation
machine, Biochim. Biophys. Acta 1823 (2012) 15–28.
[22] J.M. Flynn, S.B. Neher, Y.I. Kim, R.T. Sauer, T.A. Baker, Proteomic discovery of cellular
substrates of the ClpXP protease reveals ﬁve classes of ClpX-recognition signals, Mol.
Cell 11 (2003) 671–683.
[23] S.R. Barkow, I. Levchenko, T.A. Baker, R.T. Sauer, Polypeptide translocation by the
AAA+ ClpXP protease machine, Chem. Biol. 16 (2009) 605–612.
[24] L. Young, K. Leonhard, T. Tatsuta, J. Trowsdale, T. Langer, Role of the ABC transporter
Mdl1 in peptide export from mitochondria, Science 291 (2001) 2135–2138.
[25] A.M. Nargund, C.J. Fiorese, M.W. Pellegrino, P. Deng, C.M. Haynes, Mitochondrial and
Nuclear Accumulation of the Transcription Factor ATFS-1 promotes OXPHOS recov-
ery during the UPR(mt), Mol. Cell 58 (2015) 123–133.
[26] A. Dillin, A.L. Hsu, N. Arantes-Oliveira, J. Lehrer-Graiwer, H. Hsin, et al., Rates of be-
havior and aging speciﬁed by mitochondrial function during development, Science
298 (2002) 2398–2401.
[27] J. Feng, F. Bussiere, S. Hekimi, Mitochondrial electron transport is a key determinant
of life span in Caenorhabditis elegans, Dev. Cell 1 (2001) 633–644.
[28] C.F. Bennett, H. VanderWende, M. Simko, S. Klum, S. Barﬁeld, et al., Activation of the
mitochondrial unfolded protein response does not predict longevity in
Caenorhabditis elegans, Nat. Commun. 5 (2014) 3483.
[29] N. Al-Furoukh, J.R. Kardon, M. Kruger, M. Szibor, T.A. Baker, et al., NOA1, a novel
ClpXP substrate, takes an unexpected nuclear detour prior to mitochondrial import,
PLoS One 9 (2014) e103141.
[30] J. He, H.M. Cooper, A. Reyes, M. Di Re, L. Kazak, et al., Human C4orf14 interacts with
the mitochondrial nucleoid and is involved in the biogenesis of the small mitochon-
drial ribosomal subunit, Nucleic Acids Res. 40 (2012) 6097–6108.
[31] J. Heidler, N. Al-Furoukh, C. Kukat, I. Salwig, M.E. Ingelmann, et al., Nitric oxide-
associated protein 1 (NOA1) is necessary for oxygen-dependent regulation of mito-
chondrial respiratory complexes, J. Biol. Chem. 286 (2011) 32086–32093.
[32] M. Kolanczyk, M. Pech, T. Zemojtel, H. Yamamoto, I. Mikula, et al., NOA1 is an essential
GTPase required for mitochondrial protein synthesis, Mol. Biol. Cell 22 (2011) 1–11.
[33] M.W. Pellegrino, A.M. Nargund, C.M. Haynes, Signaling the mitochondrial unfolded
protein response, Biochim. Biophys. Acta 1833 (2013) 410–416.
[34] F. Czauderna, A. Santel, M. Hinz, M. Fechtner, B. Durieux, et al., Inducible shRNA ex-
pression for application in a prostate cancer mouse model, Nucleic Acids Res. 31
(2003) e127.
[35] A. Shevchenko, H. Tomas, J. Havlis, J.V. Olsen, M. Mann, In-gel digestion for mass
spectrometric characterization of proteins and proteomes, Nat. Protoc. 1 (2006)
2856–2860.
[36] J. Rappsilber, M. Mann, Y. Ishihama, Protocol for micro-puriﬁcation, enrichment,
pre-fractionation and storage of peptides for proteomics using StageTips, Nat.
Protoc. 2 (2007) 1896–1906.
[37] J. Cox, M. Mann, MaxQuant enables high peptide identiﬁcation rates, individualized
p.p.b.-range mass accuracies and proteome-wide protein quantiﬁcation, Nat.
Biotechnol. 26 (2008) 1367–1372.
[38] J. Cox, N. Neuhauser, A. Michalski, R.A. Scheltema, J.V. Olsen, et al., Andromeda: a
peptide search engine integrated into the MaxQuant environment, J. Proteome
Res. 10 (2011) 1794–1805.
[39] R. Ihaka, R. Gentleman, R: a language for data analysis and graphics, J. Comput.
Graph. Stat. 5 (1996) 229–314.
[40] A. Ruhs, F. Cemic, T. Braun, M. Kruger, ResA3: a web tool for resampling analysis of
arbitrary annotations, PLoS One 8 (2013) e53743.
[41] N. Al-Furoukh, S. Goffart, M. Szibor, S. Wanrooij, T. Braun, Binding to G-quadruplex
RNA activates the mitochondrial GTPase NOA1, Biochim. Biophys. Acta 1833 (2013)
2933–2942.
[42] T. Braun, M. Gautel, Transcriptional mechanisms regulating skeletal muscle differen-
tiation, growth and homeostasis, Nat. Rev. Mol. Cell Biol. 12 (2011) 349–361.
[43] R. Edgar, M. Domrachev, A.E. Lash, Gene Expression Omnibus: NCBI gene expression
and hybridization array data repository, Nucleic Acids Res. 30 (2002) 207–210.
[44] T. Barrett, S.E. Wilhite, P. Ledoux, C. Evangelista, I.F. Kim, et al., NCBI GEO: archive for
functional genomics data sets — update, Nucleic Acids Res. 41 (2013) D991–D995.
[45] I.H. Chen, M. Huber, T. Guan, A. Bubeck, L. Gerace, Nuclear envelope transmembrane
proteins (NETs) that are up-regulated during myogenesis, BMC Cell Biol. 7 (2006) 38.
[46] L. Wilson, Q. Yang, J.D. Szustakowski, P.S. Gullicksen, R. Halse, Pyruvate induces mi-
tochondrial biogenesis by a PGC-1 alpha-independent mechanism, Am. J. Physiol.
Cell Physiol. 292 (2007) C1599–C1605.
[47] E. Eden, D. Lipson, S. Yogev, Z. Yakhini, Discovering motifs in ranked lists of DNA se-
quences, PLoS Comput. Biol. 3 (2007) e39.
[48] E. Eden, R. Navon, I. Steinfeld, D. Lipson, Z. Yakhini, GOrilla: a tool for discovery and
visualization of enriched GO terms in ranked gene lists, BMC Bioinformatics 10
(2009) 48.
[49] A. Wredenberg, M. Lagouge, A. Bratic, M.D. Metodiev, H. Spahr, et al., MTERF3 regu-
lates mitochondrial ribosome biogenesis in invertebrates and mammals, PLoS
Genet. 9 (2013) e1003178.
[50] S. Santagata, D. Bhattacharyya, F.H. Wang, N. Singha, A. Hodtsev, et al., Molecular
cloning and characterization of a mouse homolog of bacterial ClpX, a novel
2591N. Al-Furoukh et al. / Biochimica et Biophysica Acta 1853 (2015) 2580–2591mammalian class II member of the Hsp100/Clp chaperone family, J. Biol. Chem. 274
(1999) 16311–16319.
[51] T. Braun, E. Bober, M.A. Rudnicki, R. Jaenisch, H.H. Arnold, MyoD expression marks
the onset of skeletal myogenesis in Myf-5 mutant mice, Development 120 (1994)
3083–3092.
[52] R.C. Scarpulla, Transcriptional paradigms in mammalian mitochondrial biogenesis
and function, Physiol. Rev. 88 (2008) 611–638.
[53] R.C. Scarpulla, Metabolic control of mitochondrial biogenesis through the PGC-1
family regulatory network, Biochim. Biophys. Acta 1813 (2011) 1269–1278.
[54] R.A. Butow, N.G. Avadhani, Mitochondrial signaling: the retrograde response, Mol.
Cell 14 (2004) 1–15.
[55] S.M. Jazwinski, The retrograde response: when mitochondrial quality control is not
enough, Biochim. Biophys. Acta 1833 (2013) 400–409.
[56] R.D. Martinus, G.P. Garth, T.L. Webster, P. Cartwright, D.J. Naylor, et al., Selective
induction of mitochondrial chaperones in response to loss of the mitochondrial
genome, Eur. J. Biochem. 240 (1996) 98–103.
[57] D. Moreno-Lastres, F. Fontanesi, I. Garcia-Consuegra, M.A. Martin, J. Arenas, et al.,
Mitochondrial complex I plays an essential role in human respirasome assembly,
Cell Metab. 15 (2012) 324–335.[58] R. Acin-Perez, P. Fernandez-Silva, M.L. Peleato, A. Perez-Martos, J.A. Enriquez,
Respiratory active mitochondrial supercomplexes, Mol. Cell 32 (2008) 529–539.
[59] F. Fischer, A. Weil, A. Hamann, H.D. Osiewacz, Human CLPP reverts the longevity
phenotype of a fungal ClpP deletion strain, Nat. Commun. 4 (2013) 1397.
[60] S. Gispert, D. Parganlija, M. Klinkenberg, S. Drose, I. Wittig, et al., Loss of mitochon-
drial peptidase Clpp leads to infertility, hearing loss plus growth retardation via ac-
cumulation of CLPX, mtDNA and inﬂammatory factors, Hum. Mol. Genet. 22 (2013)
4871–4887.
[61] M.D. Siegelin, T. Dohi, C.M. Raskett, G.M. Orlowski, C.M. Powers, et al., Exploiting the
mitochondrial unfolded protein response for cancer therapy in mice and human
cells, J. Clin. Invest. 121 (2011) 1349–1360.
[62] F. Hu, F. Liu, Mitochondrial stress: a bridge between mitochondrial dysfunction and
metabolic diseases? Cell. Signal. 23 (2011) 1528–1533.
[63] V. Jovaisaite, J. Auwerx, Themitochondrial unfolded protein response-synchronizing
genomes, Curr. Opin. Cell Biol. 33 (2015) 74–81.
